Analysis of the Effects of Levonorgestrel Releasing Intrauterine System on Preventing the Recurrence of Adenomyosis after Transcervical Resection of Endometrium
article
OA: closed
CC0
AI-generated summary
This study found that placing a levonorgestrel-releasing intrauterine system after transcervical resection of the endometrium significantly reduced adenomyosis recurrence rates compared to surgery alone, particularly in patients with smaller uterines.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective To analyze the effects of levonorgestrel releasing intrauterine system on preventing the recurrence of adenomyosis after Transcervical Resection of Endometrium(TCRE).Methods 168 adenomyosis patients who suffered from dysmenorrhea and menorrhagia were randomized allocated into experimental group and the control group(TCRE only),with 84 objects each group.Indicators including dysmenorrhea score(VAS),pictorial blood loss assessment chart(PBAC),size of uterine measured by B ultrosound and CA125 were followed up 3months,12months,24months and 36months after the operation respectively.Results There were 6 patients in the experimental group who recurred after the operation,the recurrence rate was 7.14%.Numbers of patients with recurrence were 0,2 and 4 respectively at 12 months,24 months and 36 months after operation.And of all the recurrent cases,4 cases were younger than 40 years old,accounting for 66.67%.18 patients recurred in the TCRE group,with the recurrence rate of 21.43%.It appeared 4,6 and 8 recurrent cases at 12 months,24 months and 36 months after operation respectively.And of all the recurrent cases,12 cases younger than 40 years old,accounted for 66.67%.10 patients,whose uterine sizes larger than 12 gestational weeks and with visible adenomyoma,recurred after operation,accounting for 41.67% of the total recurrence number.Conclusion The placement of levonorgestrel releasing intrauterine system after TCRE can degrade the recurrence rate of adnnomyosis.Patients whose uterine size was larger than 12 gestational weeks and with visible adenomyoma should be treated with another therapeutic methods.
My notes (saved in your browser only)
Outcome instruments
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK